Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

ISX-9 helps stem cells heal lung injury better by boosting growth factor secretion.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

ILC1 cells contribute to hair loss in alopecia areata.

IL-1α levels are higher in alopecia areata patients, suggesting a role in the disease.

Photobiomodulation can influence gene and protein expression related to healing and inflammation.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Baricitinib may effectively treat oral lichen planus.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

Combining low-level laser therapy with topical corticosteroids effectively improved Lichen Planopilaris symptoms.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

ILC1-like cells can cause alopecia areata by themselves.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.